Relative bioavailability of different buprenorphine formulations under chronic dosing conditions
- 9 April 2004
- journal article
- research article
- Published by Elsevier in Drug and Alcohol Dependence
- Vol. 74 (1) , 37-43
- https://doi.org/10.1016/j.drugalcdep.2003.11.008
Abstract
No abstract availableKeywords
This publication has 23 references indexed in Scilit:
- Clinical efficacy of buprenorphine: comparisons to methadone and placeboDrug and Alcohol Dependence, 2003
- Buprenorphine and naloxone co-administration in opiate-dependent patients stabilized on sublingual buprenorphineDrug and Alcohol Dependence, 2000
- Buprenorphine dosing every 1, 2, or 3 days in opioid-dependent patientsPsychopharmacology, 1999
- Buprenorphine versus methadone maintenance for the treatment of opioid dependenceAddiction, 1999
- Relationship of plasma buprenorphine and norbuprenorphine to withdrawal symptoms during dose induction, maintenance and withdrawal from sublingual buprenorphineAddiction, 1998
- Alternate-day buprenorphine dosing is preferred to daily dosing by opioid-dependent humans.Psychopharmacology, 1998
- A Controlled Trial Comparing Buprenorphine and Methadone Maintenance in Opioid DependenceArchives of General Psychiatry, 1996
- Structured Clinical Interview for DSM-III-R Personality DisordersPublished by American Psychological Association (APA) ,1995
- Buprenorphine versus Methadone Maintenance for Opioid DependenceJournal of Nervous & Mental Disease, 1993
- A controlled trial of buprenorphine treatment for opioid dependencePublished by American Medical Association (AMA) ,1992